Disc Medicine
IRON
61.18
-0.47
-0.76%
Disc Medicine
US · IRON
#2647 by market cap
Listed 1970
61.18
-0.47
-0.76%
Live - 5344 symbols - heartbeat 224s ago
· 2026-10-08 07:13
Pre-market
60.70
-0.78%
After-hours
61.12
-0.10%
- Market cap
- 2.35B
- P/E (TTM)i
- -9.28
- P/Bi
- 3.65
- EPSi
- -6.01
- Div yieldi
- 0.00%
- 52W posi
- 36%
Reader sentiment
Are you bullish or bearish on IRON?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Company notice
*ST Bayi Steel: Reply to the Inquiry Letter Regarding the Review of the Application Documents for the Issuance of Shares to Specific Investors by Xinjiang Bayi Iron & Steel Co., Ltd.SZSI · 2026/10/1
-
Rating change
LifeSci Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $100Market Newswire · 2026/9/10
-
Company notice
Iron Mountain | 4: Statement of changes in beneficial ownership of securities-Director Samuels Theodore R. IISEC · 2026/10/6
-
UBS Initiates CHAMPION IRON LTD(CIAFF.US) With Buy Rating, Announces Target Price $2.89Market Newswire · 2026/9/29
-
Rating change
Baoshan Iron & Steel Co., Ltd. (600019): Profitability Remains Leading; High Dividend Yield Expected to PersistCathay Haitong Securities · 2026/9/24
-
Iron Mountain(IRM.US) Officer Sells US$4.25 Million in Common StockMarket Newswire · 2026/10/6
-
Maanshan Iron & Steel Co., Ltd. (600808.SH): Appointed Chen Guorong as Deputy General Manager and Chief Financial OfficerGelonghui Finance · 2026/9/29
-
Company notice
*ST Bayi Steel: Explanation by Tianjian Certified Public Accountants (Special General Partnership) Regarding Financial Matters in the Inquiry Letter on the Review of Xinjiang Bayi Iron & Steel Co., Ltd.'s Issuance of Shares to Specific InvestorsSZSI · 2026/10/1
-
Maanshan Iron & Steel Company Limited (600808.SH): Jiang Yuxiang Elected as Chairman of the BoardGelonghui Finance · 2026/9/29
-
Rating change
BMO Capital Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $100Market Newswire · 2026/9/11
-
Rating change
Wells Fargo Maintains Disc Medicine(IRON.US) With Buy Rating, Raises Target Price to $86Market Newswire · 2026/9/16
-
Rating change
Rothschild & Co Redburn Initiates Iron Mountain(IRM.US) With Buy Rating, Announces Target Price $132Market Newswire · 2026/9/21
-
Rating change
H.C. Wainwright Maintains Disc Medicine(IRON.US) With Buy Rating, Maintains Target Price $120Market Newswire · 2026/9/22
-
Rating change
Champion Iron Price Target Cut 29% to A$4.80/Share by MacquarieDow Jones · 2026/10/2
-
Rating change
Stifel Maintains Iron Mountain(IRM.US) With Buy Rating, Maintains Target Price $140Market Newswire · 2026/9/18
-
Company notice
*ST Bayi Steel: Supplementary Legal Opinion of King & Wood Mallesons Shanghai regarding the 2026 issuance of A‑shares to specific investors by Xinjiang Bayi Iron & Steel Co., Ltd.SZSI · 2026/10/1
-
Maanshan Iron & Steel Co., Ltd. (600808.SH): Appoints Fu Ming as General ManagerGelonghui Finance · 2026/9/29
-
Rating change
Liuzhou Iron & Steel Co., Ltd. (601003): A leading steel producer in the Guangxi region, with equity production capacity poised for further expansion.Everbright Securities · 2026/9/30
-
Rating change
Truist Financial Maintains Disc Medicine(IRON.US) With Buy RatingMarket Newswire · 2026/9/21
-
Company notice
Shandong Iron & Steel: Announcement on the Progress of Share Purchases by Senior Management of Shandong Iron & Steel Co., Ltd.SZSI · 2026/10/1
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 07:13:37 · For reference only, not investment advice and not tailored to your situation.